Overview

Safety and Efficacy of Sodium Nitrite in Sickle Cell Disease

Status:
Terminated
Trial end date:
2012-06-01
Target enrollment:
Participant gender:
Summary
This study will determine if administration of sodium nitrite is safe and can improve small vessel blood flow and tissue oxygenation when given as an additional treatment in patients with acute vaso-occlusive crisis (pain crisis) associated with sickle cell disease.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Children's Hospital Los Angeles
Collaborator:
Hope Pharmaceuticals